193 related articles for article (PubMed ID: 29661456)
1. Severe Renal Allograft Rejection Resulting from Lenalidomide Therapy for Multiple Myeloma: Case Report.
Walavalkar V; Adey DB; Laszik ZG; Jen KY
Transplant Proc; 2018 Apr; 50(3):873-876. PubMed ID: 29661456
[TBL] [Abstract][Full Text] [Related]
2. Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma.
Lum EL; Huang E; Bunnapradist S; Pham T; Danovitch G
Am J Kidney Dis; 2017 May; 69(5):701-704. PubMed ID: 28189378
[TBL] [Abstract][Full Text] [Related]
3. Fatal cardiac and renal allograft rejection with lenalidomide therapy for light-chain amyloidosis.
Meyers DE; Adu-Gyamfi B; Segura AM; Buja LM; Mallidi HR; Frazier OH; Rice L
Am J Transplant; 2013 Oct; 13(10):2730-3. PubMed ID: 23914832
[TBL] [Abstract][Full Text] [Related]
4. [The use of lenalidomide in the treatment of multiple myeloma].
Holánek M; Hájek R
Klin Onkol; 2010; 23(2):67-72. PubMed ID: 20465083
[TBL] [Abstract][Full Text] [Related]
5. Neutrophilic dermatosis complicating lenalidomide therapy.
Thieu KP; Rosenbach M; Xu X; Kist JM
J Am Acad Dermatol; 2009 Oct; 61(4):709-10. PubMed ID: 19577327
[TBL] [Abstract][Full Text] [Related]
6. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
Boruah PK; Bolesta S; Shetty SM
Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
[TBL] [Abstract][Full Text] [Related]
7. A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
Dasanu CA; Alexandrescu DT
Eur J Haematol; 2009 Mar; 82(3):231-4. PubMed ID: 19018868
[TBL] [Abstract][Full Text] [Related]
8. Lenalidomide: the emerging role of a novel targeted agent in malignancies.
Kalmadi S; Baz R; Mahindra A
Drugs Today (Barc); 2007 Feb; 43(2):85-95. PubMed ID: 17353946
[TBL] [Abstract][Full Text] [Related]
9. Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.
Mariz JM; Esteves GV
Curr Opin Oncol; 2012 Jan; 24 Suppl 2():S3-11. PubMed ID: 22245806
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of lenalidomide in the treatment of hematologic malignancies.
Kastritis E; Dimopoulos MA
Expert Opin Pharmacother; 2007 Mar; 8(4):497-509. PubMed ID: 17309344
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.
García-Muñoz R; Robles-de-Castro D; Muñoz-Rodríguez A; Rabasa P
Leuk Lymphoma; 2013 Dec; 54(12):2753-5. PubMed ID: 23488662
[No Abstract] [Full Text] [Related]
12. Lenalidomide and its role in the management of multiple myeloma.
Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
[TBL] [Abstract][Full Text] [Related]
13. Transiently Pink-Tinged Serum in a Patient With Multiple Myeloma and Anemia Undergoing Lenalidomide Treatment.
Wedel W; Sofronescu AG
Am J Clin Pathol; 2015 Aug; 144(2):329-32. PubMed ID: 26185319
[TBL] [Abstract][Full Text] [Related]
14. How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide.
Kastritis E; Dimopoulos M
Leuk Lymphoma; 2007 Dec; 48(12):2295-7. PubMed ID: 18066998
[No Abstract] [Full Text] [Related]
15. Comparative effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma in the United States of America: A population-based cohort study.
Luo J; Gagne JJ; Landon J; Avorn J; Kesselheim AS
Eur J Cancer; 2017 Jan; 70():22-33. PubMed ID: 27866096
[TBL] [Abstract][Full Text] [Related]
16. How lenalidomide is changing the treatment of patients with multiple myeloma.
Dimopoulos MA; Terpos E; Niesvizky R
Crit Rev Oncol Hematol; 2013 Oct; 88 Suppl 1():S23-35. PubMed ID: 23816163
[TBL] [Abstract][Full Text] [Related]
17. Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.
Iino M
Int J Hematol; 2012 Feb; 95(2):223-4. PubMed ID: 22198829
[No Abstract] [Full Text] [Related]
18. Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence?
Kreiniz N; Khateeb A; Gino-Moor S; Polliack A; Tadmor T
Anticancer Res; 2016 Jun; 36(6):2889-92. PubMed ID: 27272801
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers.
Oehrlein K; Langer C; Sturm I; Pönisch W; Hahn-Ast C; Kuhn S; Weisel KC
Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):191-6. PubMed ID: 22341857
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Multiple Myeloma in a Heart Transplant Recipient.
Xie L; Jozwik B; Weeks P; Buja LM; Brown R; Nathan S; Rajagopal K; Paruthi C; Kar B; Loyalka P; Rajapreyar I
Prog Transplant; 2017 Mar; 27(1):65-68. PubMed ID: 27885144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
